Cisplatin nephrotoxicity as a model of chronic kidney disease

Cerda, 2008, Epidemiology of acute kidney injury, Clin J Am Soc Nephrol, 3, 881, 10.2215/CJN.04961107 Susantitaphong, 2013, World incidence of AKI: a meta-analysis, Clin J Am Soc Nephrol, 8, 1482, 10.2215/CJN.00710113 Bouchard, 2016, Acute kidney injury in western countries, Kidney Dis, 2, 103, 10.1159/000445091 Case, 2013, Epidemiology of acute kidney injury in the intensive care unit, Crit Care Res Pract, 2013, 479730 Ali, 2007, Incidence and outcomes in acute kidney injury: a comprehensive population-based study, J Am Soc Nephrol, 18, 1292, 10.1681/ASN.2006070756 Hsu, 2012, Yes, AKI truly leads to CKD, J Am Soc Nephrol, 23, 967, 10.1681/ASN.2012030222 Bucaloiu, 2012, Increased risk of death and de novo chronic kidney disease following reversible acute kidney injury, Kidney Int, 81, 477, 10.1038/ki.2011.405 Shi, 2016, AlphaKlotho mitigates progression of AKI to CKD through activation of autophagy, J Am Soc Nephrol, 27, 2331, 10.1681/ASN.2015060613 Hu, 2011, Klotho deficiency causes vascular calcification in chronic kidney disease, J Am Soc Nephrol, 22, 124, 10.1681/ASN.2009121311 Hu, 2015, Klotho and phosphate are modulators of pathologic uremic cardiac remodeling, J Am Soc Nephrol, 26, 1290, 10.1681/ASN.2014050465 Hu, 2017, Recombinant alpha-Klotho may be prophylactic and therapeutic for acute to chronic kidney disease progression and uremic cardiomyopathy, Kidney Int, 91, 1104, 10.1016/j.kint.2016.10.034 Faught, 2015, Drug-induced acute kidney injury in children, Br J Clin Pharmacol, 80, 901, 10.1111/bcp.12554 Sato, 2016, Nephrotoxicity of cisplatin combination chemotherapy in thoracic malignancy patients with CKD risk factors, BMC Cancer, 16, 10.1186/s12885-016-2271-8 Latcha, 2016, Long-term renal outcomes after cisplatin treatment, Clin J Am Soc Nephrol, 11, 1173, 10.2215/CJN.08070715 Walker, 1981, Methods of reduction of cisplatin nephrotoxicity, Ann Clin Lab Sci, 11, 397 Ravichandran, 2016, CD4 T cell knockout does not protect against kidney injury and worsens cancer, J Mol Med, 94, 443, 10.1007/s00109-015-1366-z Katagiri, 2016, Interstitial renal fibrosis due to multiple cisplatin treatments is ameliorated by semicarbazide-sensitive amine oxidase inhibition, Kidney Int, 89, 374, 10.1038/ki.2015.327 Gonzalez, 2005, Lipid peroxides and antioxidant enzymes in cisplatin-induced chronic nephrotoxicity in rats, Mediat Inflamm, 2005, 139, 10.1155/MI.2005.139 Torres, 2016, Three-dimensional morphology by multiphoton microscopy with clearing in a model of cisplatin-induced CKD, J Am Soc Nephrol, 27, 1102, 10.1681/ASN.2015010079 Sharp, 2016, Repeated administration of low-dose cisplatin in mice induces fibrosis, Am J Physiol Ren Physiol, 310, F560, 10.1152/ajprenal.00512.2015 Sharp, 2017, Developing better mouse models to study cisplatin-induced kidney injury, Am J Physiol Ren Physiol, 313, F835, 10.1152/ajprenal.00285.2017 Hu, 2010, Klotho deficiency is an early biomarker of renal ischemia-reperfusion injury and its replacement is protective, Kidney Int, 78, 1240, 10.1038/ki.2010.328 Hu, 2010, Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule, FASEB J, 24, 3438, 10.1096/fj.10-154765 Panesso, 2014, Klotho has dual protective effects on cisplatin-induced acute kidney injury, Kidney Int, 85, 855, 10.1038/ki.2013.489 Barker, 2015, The demonstration of alphaKlotho deficiency in human chronic kidney disease with a novel synthetic antibody, Nephrol Dial Transplant, 30, 223, 10.1093/ndt/gfu291 Moghal, 1998, The late histologic findings in diarrhea-associated hemolytic uremic syndrome, J Pediatr, 133, 220, 10.1016/S0022-3476(98)70223-9 Hu, 2012, Klotho as a potential biomarker and therapy for acute kidney injury, Nat Rev Nephrol, 8, 423, 10.1038/nrneph.2012.92 Faul, 2011, FGF23 induces left ventricular hypertrophy, J Clin Invest, 121, 4393, 10.1172/JCI46122 Kramann, 2014, Fluorescence microangiography for quantitative assessment of peritubular capillary changes after AKI in mice, J Am Soc Nephrol, 25, 1924, 10.1681/ASN.2013101121 Nematbakhsh, 2013, Gender difference in cisplatin-induced nephrotoxicity in a rat model: greater intensity of damage in male than female, Nephrourol Mon, 5, 818, 10.5812/numonthly.10128 Zhou, 2013, Loss of Klotho contributes to kidney injury by derepression of Wnt/beta-catenin signaling, J Am Soc Nephrol, 24, 771, 10.1681/ASN.2012080865 Appenroth, 1984, Age differences in cisplatinum nephrotoxicity, Toxicology, 32, 343, 10.1016/0300-483X(84)90086-6 Hrushesky, 1984, Lack of age-dependent cisplatin nephrotoxicity, Am J Med, 76, 579, 10.1016/0002-9343(84)90280-8 Kanbay, 2009, Phosphate-the silent stealthy cardiorenal culprit in all stages of chronic kidney disease: a systematic review, Blood Purif, 27, 220, 10.1159/000197562 Foley, 2009, Phosphate levels and cardiovascular disease in the general population, Clin J Am Soc Nephrol, 4, 1136, 10.2215/CJN.01660309 Striker, 2011, Phosphate and CVD: it's all in what's on the table, Arterioscler Thromb Vasc Biol, 31, 1951, 10.1161/ATVBAHA.111.231928 Toussaint, 2012, Phosphate in early chronic kidney disease: associations with clinical outcomes and a target to reduce cardiovascular risk, Nephrology, 17, 433, 10.1111/j.1440-1797.2012.01618.x Li, 2014, Can serum levels of alkaline phosphatase and phosphate predict cardiovascular diseases and total mortality in individuals with preserved renal function? A systemic review and meta-analysis, PLoS ONE, 9, e102276, 10.1371/journal.pone.0102276 Isakova, 2015, Rationale and approaches to phosphate and fibroblast growth factor 23 reduction in CKD, J Am Soc Nephrol, 26, 2328, 10.1681/ASN.2015020117 Jozefacki, 2016, Phosphate excretion is decreased in older cardiac patients with normal kidney function: an emerging dietary risk factor?, Appl Physiol Nutr Metab, 41, 452, 10.1139/apnm-2015-0176 Shen, 2016, Phosphate-induced renal fibrosis requires the prolyl isomerase pin1, PLoS ONE, 11, e0150093, 10.1371/journal.pone.0150093 Vervloet, 2017, The role of phosphate in kidney disease, Nat Rev Nephrol, 13, 27, 10.1038/nrneph.2016.164 Bian, 2014, Alpha Klotho and phosphate homeostasis, J Endocrinol Invest, 37, 1121, 10.1007/s40618-014-0158-6 Kollerits, 2007, Gender-specific association of adiponectin as a predictor of progression of chronic kidney disease: the mild to moderate kidney disease study, Kidney Int, 71, 1279, 10.1038/sj.ki.5002191 Diwan, 2014, Gender differences in adenine-induced chronic kidney disease and cardiovascular complications in rats, Am J Physiol Ren Physiol, 307, F1169, 10.1152/ajprenal.00676.2013 Cobo, 2016, Sex and gender differences in chronic kidney disease: progression to end-stage renal disease and haemodialysis, Clin Sci, 130, 1147, 10.1042/CS20160047 Chang, 2016, Risk factors of gender for renal progression in patients with early chronic kidney disease, Medicine, 95, e4203, 10.1097/MD.0000000000004203 Carrero, 2017, Chronic kidney disease, gender, and access to care: a global perspective, Semin Nephrol, 37, 296, 10.1016/j.semnephrol.2017.02.009 Jones, 1985, Cis-diamminedichloroplatinum (II)-induced acute renal failure in the rat. Correlation of structural and functional alterations, Lab Invest, 52, 363 Chopra, 1982, Cis-diamminedichlorplatinum-induced acute renal failure in the rat, Kidney Int, 21, 54, 10.1038/ki.1982.8 Bhatt, 2010, MicroRNA-34a is induced via p53 during cisplatin nephrotoxicity and contributes to cell survival, Mol Med, 16, 409, 10.2119/molmed.2010.00002 Jiang, 2010, Self-eating for death or survival during cisplatin nephrotoxicity?, Clin Exp Nephrol, 14, 516, 10.1007/s10157-010-0324-x Yang, 2014, Mitochondrial dysregulation and protection in cisplatin nephrotoxicity, Arch Toxicol, 88, 1249, 10.1007/s00204-014-1239-1 Safirstein, 1981, Cisplatin nephrotoxicity in rats: defect in papillary hypertonicity, Am J Physiol, 241, F175 Nakada, 1986, Nephrotoxicity of cisplatin in rats, Dev Toxicol Environ Sci, 14, 179 Trujillo, 2014, Renal tight junction proteins are decreased in cisplatin-induced nephrotoxicity in rats, Toxicol Mech Methods, 24, 520, 10.3109/15376516.2014.948248 Campbell, 1983, Plasma platinum levels: relationship to cisplatin dose and nephrotoxicity, Cancer Treat Rep, 67, 169 Mulder, 2013, Glomerular function time trends in long-term survivors of childhood cancer: a longitudinal study, Cancer Epidemiol Biomark Prev, 22, 1736, 10.1158/1055-9965.EPI-13-0036 Dekkers, 2013, Long-term nephrotoxicity in adult survivors of childhood cancer, Clin J Am Soc Nephrol, 8, 922, 10.2215/CJN.09980912 Marcussen, 1990, Atubular glomeruli in cisplatin-induced chronic interstitial nephropathy, Exp Stereol Investig APMIS, 98, 1087 Okada, 2017, Alterations in cisplatin pharmacokinetics and its acute/sub-chronic kidney injury over multiple cycles of cisplatin treatment in rats, Biol Pharm Bull, 40, 1948, 10.1248/bpb.b17-00499 Reyes, 2005, Gender differences in hypertension and kidney disease, Med Clin North Am, 89, 613, 10.1016/j.mcna.2004.11.010 Kummer, 2012, The influence of gender and sexual hormones on incidence and outcome of chronic kidney disease, Pediatr Nephrol, 27, 1213, 10.1007/s00467-011-1963-1 Eriksen, 2006, The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age, Kidney Int, 69, 375, 10.1038/sj.ki.5000058 Kurosu, 2005, Suppression of aging in mice by the hormone Klotho, Science, 309, 1829, 10.1126/science.1112766 Fan, 2017, Aging-associated metabolic disorder induces Nox2 activation and oxidative damage of endothelial function, Free Radic Biol Med, 108, 940, 10.1016/j.freeradbiomed.2017.05.008 Wulfert, 2012, Age-dependent role of microvascular endothelial and polymorphonuclear cells in lipopolysaccharide-induced acute kidney injury, Anesthesiology, 117, 126, 10.1097/ALN.0b013e31825b57c9 Wang, 2014, The aging kidney: increased susceptibility to nephrotoxicity, Int J Mol Sci, 15, 15358, 10.3390/ijms150915358 Zhou, 2017, Changes in macroautophagy, chaperone-mediated autophagy, and mitochondrial metabolism in murine skeletal and cardiac muscle during aging, Aging (Albany NY), 9, 583, 10.18632/aging.101181 Lu, 2017, Klotho/FGF23 axis in chronic kidney disease and cardiovascular disease, Kidney Dis, 3, 15, 10.1159/000452880 Neyra, 2017, Potential application of klotho in human chronic kidney disease, Bone, 100, 41, 10.1016/j.bone.2017.01.017